Brendel Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,883
Closed -$2.42M 111
2021
Q3
$2.42M Sell
3,883
-834
-18% -$560K 2.88% 14
2021
Q2
$2.98M Sell
4,717
-626
-12% -$346K 1.64% 19
2021
Q1
$2.61M Sell
5,343
-699
-12% -$350K 1.75% 25
2020
Q4
$3.02M Sell
6,042
-50
-0.8% -$22.4K 2.05% 20
2020
Q3
$2.4M Sell
6,092
-325
-5% -$120K 1.92% 21
2020
Q2
$2.12M Sell
6,417
-24
-0.4% -$6.95K 1.83% 23
2020
Q1
$1.56M Buy
6,441
+821
+15% +$214K 1.84% 24
2019
Q4
$1.47M Sell
5,620
-2,205
-28% -$581K 1.25% 34
2019
Q3
$2.13M Buy
7,825
+93
+1% +$25.9K 1.91% 20
2019
Q2
$2.13M Sell
7,732
-1,682
-18% -$414K 2.06% 18
2019
Q1
$2.1M Buy
+9,414
New +$1.94M 1.89% 21

Other funds holding IDXX

Brendel Financial Advisors's IDXX Position: Q4 2021 in Review

Brendel Financial Advisors sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 3,883 shares — an estimated $2.42M sold.

Brendel Financial Advisors first reported a position in IDXX in Q1 2019 and held it in 11 quarters. The position peaked at $3.02M in Q4 2020. 1,106 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • Brendel Financial Advisors reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • Brendel Financial Advisors sold 3,883 Idexx Laboratories shares in Q4 2021, an estimated $2.42M.
  • Brendel Financial Advisors first reported a position in Idexx Laboratories in Q1 2019 and held it in 11 quarters.
  • Brendel Financial Advisors's Idexx Laboratories position peaked at $3.02M in Q4 2020.
  • 1,106 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Brendel Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.